Business Context and Reporting Period
This Form 8-K filing by iRadimed Corporation (IRMD) covers the reporting period of February 2, 2023. The report details a material definitive agreement regarding the acquisition of real property in Orange County, Florida.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data point disclosed is the transaction value for the real estate acquisition.
- Acquisition Cost: $6,200,000
- Asset Acquired: Approximately 26.518 acres of land
- Counterparty: O Property, Ltd.
Material Changes
The Company entered into a Reinstatement and Amendment to a Sale and Purchase Agreement originally dated November 1, 2022. This action resulted in the consummation of the sale of the aforementioned land to the Company. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors related to future operations. The document focuses solely on the execution of the real estate transaction. The text notes that the description of the agreement is qualified by reference to the full Purchase Agreement filed as Exhibit 10.1.
Investor Verification Checklist
- Verify the terms and conditions of the Reinstatement and Amendment in Exhibit 10.1.
- Confirm the funding source for the $6,200,000 land purchase in subsequent financial statements.
- Review the intended use of the 26.518 acres of land in Orange County, Florida.
- Check for any subsequent filings regarding the integration of this asset into the Company's operations.